Fullstory Has Strong First Half of 2024: Grows Enterprise Customer Base, Welcomes Two New Executives, and Celebrates Fourth Consecutive Year on Inc. 5000 List
September 19, 2024 09:53 ET
|
FullStory
Fullstory sees double-digit customer growth upmarket and significant traction with its behavioral data solution.
DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Extreme Networks
September 19, 2024 09:52 ET
|
Faruqi & Faruqi LLP
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Extreme Networks To Contact Him Directly To Discuss Their...
Mimecast Earns a “Strong Performer” Recognition in Inaugural Human Risk Management Solutions Report
September 19, 2024 09:50 ET
|
Mimecast Limited
LEXINGTON, Mass., Sept. 19, 2024 (GLOBE NEWSWIRE) -- Mimecast, a leading global Human Risk Management platform, today announced it has been recognized as a strong performer in The Forrester Wave™:...
Leap Distributors Acquires Leap Surgical and DUB Enterprises: Partnership Positions Company for Continued Growth
September 19, 2024 09:47 ET
|
Leap Distributors
Leap Distributors has acquired Leap Surgical and DUB Enterprises. The three companies will operate as one under the Leap Distributors umbrella.
Bavarian Nordic Receives EMA Approval of Mpox Vaccine for Adolescents
September 19, 2024 09:45 ET
|
Bavarian Nordic A/S
MVA-BN approved for use against mpox and smallpox in adolescents 12-17 years of age after expedited review with EMARepresents the second EMA approval of an MVA-BN-based vaccine for a younger...
Two Life-Saving Marrow Donors Meet Their Transplant Recipients at Gift of Life Marrow Registry Charitable Gala
September 19, 2024 09:44 ET
|
Gift of Life Marrow Registry
Gift of Life Marrow Registry celebrated its annual One Huge Night Los Angeles Gala on September 16 at the Beverly Wilshire Hotel in Los Angeles, Calif.
Crohn's Disease Therapeutics Pipeline Research Report 2024: Comprehensive Insights About 70+ Companies and 80+ Drugs
September 19, 2024 09:43 ET
|
Research and Markets
Dublin, Sept. 19, 2024 (GLOBE NEWSWIRE) -- The "Crohn's Disease - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This "Crohn's Disease - Pipeline...
Traveler's Diarrhea Therapeutics Pipeline Market Report 2024 Featuring Immuron, Scandinavian Biopharma, and Sigmoid Pharma
September 19, 2024 09:42 ET
|
Research and Markets
Dublin, Sept. 19, 2024 (GLOBE NEWSWIRE) -- The "Traveler's Diarrhea - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This "Traveler's Diarrhea -...
Groundbreaking Market Report Forecasts Significant Growth in Cancer Immunotherapy by 2027
September 19, 2024 09:41 ET
|
Research and Markets
Dublin, Sept. 19, 2024 (GLOBE NEWSWIRE) -- The "Cancer Immunotherapy Markets. The Race for the Cures. Market Forecasts for Immuno-Oncology Therapeutics by Therapy, by Cancer and by Customer...
DAVA INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Endava plc Investors with Substantial Losses Have Opportunity to Lead Case
September 19, 2024 09:40 ET
|
Robbins Geller Rudman & Dowd LLP
SAN DIEGO, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Endava plc (NYSE: DAVA) securities between May 23, 2023 and February 28,...